10 completed, 5 active not recruiting, 2 recruiting, 1 not yet recruiting. 18 Phase 3.
By phase and status
Follow cagrilintide: new trials by email Literature Review of cagrilintide trials Research Report on cagrilintide
Trials (filtered) newest first · largest first
All 18 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity CagriSema, Semaglutide, Cagrilintide - Hypertension, Obesity Phase 3 Not yet recruiting 1408 2026-11-11 2026-11-05
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight Cagrilintide, Placebo cagrilintide, Placebo semaglutide - Overweight, Obesity Phase 3 Recruiting 285 2026-08-04 2026-09-04
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight Cagrilintide, Semaglutide, Placebo cagrilintide - Overweight, Obesity Phase 3 Recruiting 460 2026-01-08 2026-09-30
Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide Cagrilintide, Placebo - Obesity, Overweight Phase 3 Active not recruiting 300 2025-11-05 2026-08-06
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide Cagrilintide, Placebo (matched to Cagrilintide) - Overweight, Obesity Phase 3 Active not recruiting 330 2025-11-05 2026-11-16
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity Cagrilintide, Semaglutide, Placebo cagrilintide - Obesity Phase 3 Active not recruiting 400 2025-02-10 2026-01-20
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both Cagrilintide, Semaglutide, Tirzepatide - Diabetes Mellitus, Type 2 Phase 3 Completed 1023 2024-11-05 2026-10-19
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight Cagrilintide, Semaglutide, Placebo - Obesity Phase 3 Completed 300 2024-06-24 2026-05-05
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin Cagrilintide, Semaglutide, Placebo - Type 2 Diabetes Phase 3 Completed 274 2024-03-26 2026-09-09
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise Cagrilintide, Semaglutide, Placebo - Type 2 Diabetes Phase 3 Completed 189 2024-03-19 2026-09-30
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Cagrilintide, Semaglutide, Tirzepatide - Type 2 Diabetes Phase 3 Completed 1024 2024-01-16 2026-10-19
A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight Cagrilintide, Semaglutide, Tirzepatide - Obesity Phase 3 Completed 809 2023-11-27 2026-02-06
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Cagrilintide, Semaglutide, Placebo cagrilintide - Type 2 Diabetes Mellitus Phase 3 Completed 2734 2023-09-27 2026-11-19
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight Cagrilintide, Semaglutide, Placebo Semaglutide - Obesity or Overweight Phase 3 Completed 300 2023-08-15 2026-01-09
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight Cagrilintide, Semaglutide, Placebo Semaglutide - Obesity or Overweight Phase 3 Completed 331 2023-04-03 2026-01-22
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels Cagrilintide, Semaglutide, Placebo - Cardiovascular Disease Phase 3 Active not recruiting 7101 2023-03-01 2026-08-31
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight Cagrilintide, Semaglutide, Placebo cagrilintide - Overweight, Obesity Phase 3 Completed 1200 2023-02-01 2026-01-28
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight Cagrilintide, Semaglutide, Placebo cagrilintide - Obesity Phase 3 Active not recruiting 3400 2022-11-01 2026-09-30
Conditions studied Obesity (12) · Diabetes Mellitus, Type 2 (7) · Overweight (7) · Cardiovascular Diseases (1) · Hypertension (1)
Sponsors Novo Nordisk A/S (18)
Countries United States (16) · Canada (11) · United Kingdom (10) · Poland (9) · Argentina (8) · Australia (8) · Germany (8) · Hungary (8) · India (7) · Italy (7) · Japan (7) · Serbia (7) · Denmark (6) · South Africa (6) · Spain (6)
Results publications PMID 40544432 , PMID 40544433 , PMID 41328546 , PMID 42009015 , PMID 42251856 , PMID 42251859 , PMID 42251860 , PMID 42838477
NIH funding 2023 (4) , 2025 (1)